×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概览
Brought to you by DIA in cooperation with
COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have different needs then large pharmaceutical companies. When companies are conducting studies for therapeutic areas such as oncology, or are conducting clinical trials for next generation therapies, a smaller sponsor requires a partner that is nimble, fast acting and flexible, as well as transparent. Communicating what is required is vital, but even more important, having a partner that can communicate what is possible is key. This webinar will outline the 3 areas that mid-tier biotech companies need from CROs, which are people, process and technology.